Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Total Debt (2018 - 2026)

Profound Medical has reported Total Debt over the past 7 years, most recently at $4.5 million for Q4 2025.

  • For Q4 2025, Total Debt fell 3.48% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $4.5 million, down 3.48%, while the annual FY2025 figure was $4.5 million, 3.48% down from the prior year.
  • Total Debt for Q4 2025 was $4.5 million at Profound Medical, roughly flat from $4.5 million in the prior quarter.
  • Over five years, Total Debt peaked at $6.2 billion in Q1 2023 and troughed at $1.4 million in Q4 2021.
  • A 5-year average of $393.4 million and a median of $4.5 million in 2025 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: surged 338269.57% in 2023 and later crashed 99.93% in 2024.
  • Year by year, Total Debt stood at $1.4 million in 2021, then soared by 408.07% to $7.2 million in 2022, then fell by 0.98% to $7.1 million in 2023, then tumbled by 34.39% to $4.7 million in 2024, then fell by 3.48% to $4.5 million in 2025.
  • Business Quant data shows Total Debt for PROF at $4.5 million in Q4 2025, $4.5 million in Q3 2025, and $4.5 million in Q2 2025.